Generic Name and Formulations:
Iohexol 9.7g (equivalent to 4.5g carbon bound iodine); per bottle; pwd for oral soln after reconstitution.
Otsuka America Pharmaceutical, Inc.
Indications for ORALTAG:
For opacification of the gastrointestinal (GI) tract during computed tomography (CT) of the abdomen and pelvis.
Limitations Of use:
Not for diagnostic examination of the GI tract.
Adults and Children:
Administer 20–60mins before imaging. <3yrs: up to 4.5g iodine (1 bottle); max 4.5g total iodine dose. 3–18yrs: up to 9g iodine (<1–2 bottles); max 9g total iodine dose. >18yrs: 4.5–9g iodine (1–2 bottles); max 9g total iodine dose. For higher concentration preparation at lower volumes: see full labeling.
Do not administer Oraltag parenterally; risk of severe reactions (eg, sepsis). Previous reaction to an iodinated contrast agent. Allergic disorders. Have emergency resuscitation equipment and trained personnel available. Elderly. Pregnancy. Nursing mothers: consider pumping and discarding breast milk for 10hrs post-administration.
May alter results of thyroid function tests; if indicated, perform prior to administration.
Radiographic contrast medium.
Nausea, vomiting, diarrhea; hypersensitivity reactions.
Single-use bottle (20oz)—12, 25
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA Fast-Tracks Treatment for Autism Spectrum Disorder
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics